Su, Yaming, et al. “Using Novobiocin As a Specific Inhibitor of Breast Cancer Resistant Protein to Assess the Role of Transporter in the Absorption and Disposition of Topotecan”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 10, no. 4, Oct. 2007, pp. 519-36, doi:10.18433/J3QP4W.